Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Share Price sickness - Reuters agrees

Share Price sickness - Reuters agrees

posted on Sep 27, 2007 10:56AM

Reuters gives PTSC their highest overal rating (Outperform) eventhough they rate it poorly for stock price performance - no surprise. But they still rate it overal as outperform.

Technical Factors: Neutral

This rating is based on analyses of share price

movements over a variety of time periods. We

compare performance characteristics of individual

stocks with those of all the others we rate.

Generally speaking, our goal is to favor up-trending

shares that have experienced recent corrections

and de-emphasize down-trending shares

experiencing uncharacteristic periods of strength.

Here is how PTSC shares performed during the

various periods we examined.

Price Change

Past 7 days -6.6%

Past 30 days -8.7%

Past 60 days -25.9%

Change for Past 180 Days: -31.5%

Open on 3/30/07 Close on 9/25/07

$0.60

Share
New Message
Please login to post a reply